Health, Longevity & Biohacking
GLP-1 Drugs Cut Cancer Progression by Up to 50% in Major Study
Megyn Kelly Show
Trump's Newsy Cabinet Meeting, GLP-1 Drugs and Cancer, NASA Eyes Return to Moon: AM Update 5/28
What was said
"These results deserve cautious optimism. For patients managing both diabetes and cancer, the possibility that their anti-diabetic medication may also be working in their favor is an encouraging finding."
Cleveland Clinic researchers analyzing over 12,000 cancer patients found those taking GLP-1 drugs like Ozempic were significantly less likely to see their cancer progress to stage 4. The largest effect was in lung cancer patients, who showed 50% lower risk of metastasis, with substantial reductions also seen in breast, liver, and colorectal cancers. The retrospective study warrants randomized trials to confirm causation.
Verification status
Attributed speaker claim
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
Source and context
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
- Programme
- Megyn Kelly Show
- Episode
- Trump's Newsy Cabinet Meeting, GLP-1 Drugs and Cancer, NASA Eyes Return to Moon: AM Update 5/28
- Clip time
- 12:15
- Original source
- Watch the source segment →
From this episode
Megyn Kelly Show